Is the serum level of salusin-β associated with hypertension and atherosclerosis in the pediatric population?

Pediatric Nephrology

Volumn 30, Issue 3, 2015, Pages 523-531

  Kołakowska, Urszula ^a   Kuroczycka–Saniutycz, Elżbieta ^a   Wasilewska, Anna ^a   Olański, Witold ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Adolescents; Atherogenic index; Children; Essential hypertension; Salusin

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; PEPTIDE; SALUSIN BETA; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; SIGNAL PEPTIDE; TOR2A PROTEIN, HUMAN;

ADOLESCENT; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITORING; BODY MASS; CHILD; CLINICAL FEATURE; COHORT ANALYSIS; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; ESSENTIAL HYPERTENSION; FEMALE; HUMAN; HYPERTENSION; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; SYSTOLIC BLOOD PRESSURE; WHITE COAT HYPERTENSION; BLOOD;

ADOLESCENT; ATHEROSCLEROSIS; CHILD; COHORT STUDIES; FEMALE; HUMANS; HYPERTENSION; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; PROSPECTIVE STUDIES;

EID: 84925511620     PISSN: 0931041X     EISSN: 1432198X     Source Type: Journal    
DOI: 10.1007/s00467-014-2960-y     Document Type: Article

References (41)

1. Shichiri M, Ishimaru S, Ota T, Nishikawa T, Isogai T, Hirata Y (2003) Salusins: newly identified bioactive peptides with hemodynamic and mitogenic activities. Nat Med 9:1166–1172
2. Watanabe T, Sato K, Itoh F, Iso Y, Nagashima M, Hirano T, Shichiri M (2011) The roles of salusins in atherosclerosis and related cardiovascular diseases. J Am Soc Hypertens 5:359–365
3. Sato K, Koyama T, Tateno T, Hirata Y, Shichiri M (2006) Presence of immunoreactive salusin-α in human serum and urine. Peptides 27:2561–2566
4. Sato K, Sato T, Susumu T, Koyama T, Shichiri M (2009) Presence of immunoreactive salusin-β in human plasma and urine. Regul Pept 158:63–67
5. Ti Y, Wang F, Wang ZH, Wang XL, Zhang W, Zhang Y, Bu PL (2012) Associations of serum salusin-alpha levels with atherosclerosis and left ventricular diastolic dysfunction in essential hypertension. J Hum Hypertens 26:603–609
6. Watanabe T, Sato K, Itoh F, Wakabayashi K, Shichiri M, Hirano T (2012) Endogenous bioactive peptides as potential biomarkers for atherosclerotic coronary heart disease. Sensors 12:4974–4985
7. Saito T, Dayanithi G, Saito J, Onaka T, Urabe T, Watanabe TX, Hashimoto H, Yokoyama T, Fujihara H, Yokota A, Nishizawa S, Hirata Y, Ueta Y (2008) Chronic osmotic stimuli increase salusin-b-like immunoreactivity in the rat hypothalamo-neuro hypophyseal system: possible involvement of salusin-b on [Ca2+] i increase and neuro hypophyseal hormone release from the axon terminals. J Neuroendocrinol 20:207–219
8. Sato K, Watanabe R, Itoh F, Shichiri M, Watanabe T (2013) Salusins: potential use as a biomarker for atherosclerotic cardiovascular diseases. Int J Hypertens2013:965140. doi: 10.1155/2013/965140
9. Allahverdian S, Pannu PS, Francis GA (2012) Contribution of monocyte-derived macrophages and smooth muscle cells to arterial foam cell formation. Cardiovasc Res 95:165–172
10. Watanabe T, Kanome T, Miyazaki A, Katagiri T (2006) Human urotensin II as a link between hypertension and coronary artery disease. Hypertens Res 29:375–387
11. Watanabe T, Nishio K, Kanome T, Matsuyama T, Koba S, Sakai T, Sato K, Hongo S, Nose K, Ota H, Kobayashi Y, Katagiri T, Shichiri M, Miyazaki A (2008) Impact of salusin-α and -β on human macrophage foam cell formation and coronary atherosclerosis. Circulation 117:638–648
12. Urbina E, Alpert B, Flynn J, Hayman L, Harshfield GA, Jacobson M, Mahoney L, McCrindle B, Mietus-Snyder M, Steinberger J, Daniels S, American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee (2008) Ambulatory blood pressure monitoring in children and adolescents: recommendations for standard assessment: a scientific statement from the American Heart Association atherosclerosis, hypertension, and obesity in youth committee of the council on cardiovascular disease in the young and the council for high blood pressure research. Hypertension 52:433–451
13. Cole TJ, Green PJ (1992) Smoothing reference centile curves: the LMS method and penalized likelihood. Stat Med 11:1305–1319
14. Kułaga Z, Litwin M, Grajda A, Kułaga K, Gurzkowska B, Góźdź M, Pan H, OLAF Study (2010) Oscillometric blood pressure percentiles for Polish normal-weight school-aged children and adolescents. J Hypertens 30:1942–1954
15. Wühl E, Witte K, Soergel M, Mehls O, Schaefer F, German Working Group on Pediatric Hypertension (2002) Distribution of 24-h ambulatory blood pressure in children: normalized reference values and role of body dimensions. J Hypertens 20:1995–2007
16. Yoon EY, Cohn L, Rocchini A, Kershaw D, Freed G, Ascione F, Clark S (2012) Antihypertensive prescribing patterns for adolescents with primary hypertension. Pediatrics 129:e1–e8
17. Fujimoto K, Hayashi A, Kamata Y, Ogawa A, Watanabe T, Ichikawa R, Iso Y, Koba S, Kobayashi Y, Koyama T, Shichiri M (2013) Circulating levels of human salusin-β, a potent hemodynamic and atherogenesis regulator. PLoS One 8(10):e76714
18. Zhang LL, Ding L, Zhang F, Gao R, Chen Q, Li YH, Kang YM, Zhu GQ (2014) Salusin-β in rostral ventrolateral medulla increases sympathetic outflow and blood pressure via superoxide anions in hypertensive rats. J Hypertens 32:1059–1067
19. Suzuki N, Shichiri M, Tatenoa T, Satoc K, Hirata Y (2011) Distinct systemic distribution of salusin-α and salusin-β in the rat. Peptides 32:805–810
20. Suzuki N, Shichiri M, Akashi T, Sato K, Sakurada M, Hirono Y, Yoshimoto T, Koyama T, Hirata Y (2007) Systemic distribution of salusin expression in the rat. Hypertens Res 30(12):1255–1262
21. Ren AJ, Liang Q, Wang R, Ji HY, Wu Y, Shi JS, Lin L, Yuan WJ (2013) Effects of salusin-β on action potential and ionic currents in ventricular myocytes of rats. Acta Physiol 207:166–172
22. Sato K, Fujimoto K, Koyama T, Shichiri M (2010) Release of salusin-β from human monocytes/macrophages. Regul Pept 162:68–72
23. Nakayama C, Shichiri M, Sato K, Hirata Y (2009) Expression of prosalusin in human neuroblastoma cells. Peptides 30:1362–1367
24. Sato K, Koyama T, Shichiri M (2008) Biosynthesis and secretion of salusin-alpha from human cells. Peptides 29:2203–2207
25. Aydina S, Erenb MN, Aydinc S, Ozercand IH, Daglid AF (2012) The bioactive peptides salusins and apelin-36 are produced in human arterial and venous tissues and the changes of their levels during cardiopulmonary bypass. Peptides 37:233–239
26. Matsumura K (2014) Editorial comment: salusin and central regulation of blood pressure in hypertension. J Hypertens 32:981–982
27. Izumiyama H, Tanaka H, Egi K, Sunamori M, Hirata Y, Shichiri M (2005) Synthetic salusins as cardiac depressors in rats. Hypertension 45:419–425
28. Gabor A, Leenen FH (2012) Central neuromodulatory pathways regulating sympathetic activity in hypertension. J Appl Physiol 113:1294–1303
29. Takenoya F, Hori T, Kageyama H, Funahashi H, Takeuchi M, Kitamura Y, Shichiri M, Shioda S (2005) Coexistence of salusin and vasopressin in the rat hypothalamo-hypophyseal system. Neurosci Lett 385:110–113
30. Chen WW, Sun HJ, Zhang F, Zhou YB, Xiong XQ, Wang JJ, Zhu GQ (2013) Salusin-β in paraventricular nucleus increases blood pressure and sympathetic outflow via vasopressin in hypertensive rats. Cardiovasc Res 98:344–351
31. Marina N, Abdala AP, Korsak A, Simms AE, Allen AM, Paton JF, Gourine AV (2011) Control of sympathetic vasomotor tone by catecholaminergic C1 neurons of the rostral ventrolateral medulla oblongata. Cardiovasc Res 91:703–710
32. Guyenet PG (2006) The sympathetic control of blood pressure. Nat Rev Neurosci 7:335–346
33. Grassi G (2009) Assessment of sympathetic cardiovascular drive in human hypertension: achievements and perspectives. Hypertension 54:690–697
34. Allen AM, O’Callaghan EL, Chen D, Bassi JK (2009) Central neural regulation of cardiovascular function by angiotensin: a focus on the rostral ventrolateral medulla. Neuroendocrinology 89:361–369
35. Palm F, Onozato M, Welch WJ, Wilcox CS (2010) Blood pressure, blood flow, and oxygenation in the clipped kidney of chronic 2-kidney, 1-clip rats: effects of tempol and angiotensin blockade. Hypertension 55:298–304
36. Bergamaschi C, Campos RR, Schor N, Lopes OU (1995) Role of the rostral ventrolateral medulla in maintenance of blood pressure in rats with Goldblatt hypertension. Hypertension 26:1117–1120
37. Ross R (1999) Atherosclerosis–an inflammatory disease. N Engl J Med 340:115–126
38. Zhou CH, Liu L, Liu L, Zhang MX, Guo H, Pan J, Yin XX, Ma TF, Wu YQ (2014) Salusin-β not salusin-α promotes vascular inflammation in ApoE-deficient mice via the I kBa/NF-kB pathway. PLoS One 9:e91468
39. Watanabe T, Suguro T, Sato K, Koyama T, Nagashima M, Kodate S, Hirano T, Adachi M, Shichiri M, Miyazaki A (2008) Serum salusin-alpha levels are decreased and correlated negatively with carotid atherosclerosis in essential hypertensive patients. Hypertens Res 31:463–468
40. de Giorgis T, Marcovecchio ML, Di Giovanni I, Giannini C, Chiavaroli V, Chiarelli F, Mohn A (2013) Triglycerides-to-HDL ratio as a new marker of endothelial dysfunction in obese prepubertal children. Eur J Endocrinol 170:173–180
41. Pacifico L, Bonci E, Andreoli G, Romaggioli S, Di Miscio R, Lombardo CV, Chiesa C (2014) Association of serum triglyceride-to-HDL cholesterol ratio with carotid artery intima-media thickness, insulin resistance and nonalcoholic fatty liver disease in children and adolescents. Nutr Metab Cardiovasc Dis 24:737–743